Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. QAAGZX: which is better?

Bottom line

PRHSX vs QAAGZX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and QAAGZX (T. Rowe Price Health Sciences Portfolio) have nearly the same top holdings — their top 25 positions are about 98% the same by weight.

PRHSX is cheaper at 0.83% vs 0.86% — a difference of $3.00 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +4.1% for QAAGZX.

Updated Nov 19, 2026

PRHSX vs QAAGZX side by side

PRHSXQAAGZX
TypeMutual fundETF
Fund familyT. Rowe PriceT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.86%
Annual cost per $10k$83$86
10-yr cost on $10k (prospectus)$1,025$1,061
Max front load—None
12b-1 fee—0%
1-yr return+17.7%+18.1%
5-yr return (annualized)+4.2%+4.1%
10-yr return (annualized)+9.1%+9.0%
Best quarter+23.5%+23.4%
Worst quarter−15.8%−15.8%
Net assets (fund)$11.9B$751.7M
Number of holdings279277
Portfolio turnover62%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXQAAGZXDifference
2025+17.7%+18.1%−0.4%
2024+1.8%+1.7%+0.2%
2023+3.1%+3.0%+0.1%
2022−12.2%−12.5%+0.3%
2021+13.3%+13.1%+0.2%
2020+30.1%+29.6%+0.5%
2019+29.1%+29.0%+0.2%
2018+1.2%+1.1%+0.1%
2017+28.0%+27.6%+0.4%
2016−10.4%−10.5%+0.1%

Source: Fund prospectus bar charts

Holdings overlap

24 of PRHSX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingPRHSXQAAGZX
Eli Lilly & Co14.28%14.06%
Johnson & Johnson6.63%6.64%
Unitedhealth Group Inc5.99%5.88%
Abbvie Inc5.10%5.12%
Merck & Co. Inc.4.01%4.00%
Gilead Sciences Inc2.82%2.79%
Thermo Fisher Scientific Inc2.52%2.53%
Vertex Pharmaceuticals Inc2.28%2.26%
Bristol-myers Squibb Co2.11%2.12%
Abbott Laboratories1.89%1.91%
Intuitive Surgical Inc1.87%1.89%
Amgen Inc1.82%1.80%
Stryker Corp1.78%1.78%
Elevance Health Inc1.53%1.54%
Natera Inc1.44%1.44%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between PRHSX and QAAGZX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and QAAGZX (T. Rowe Price Health Sciences Portfolio) have nearly the same top holdings — their top 25 positions are about 98% the same by weight. PRHSX is cheaper at 0.83% vs 0.86% — a difference of $3.00 a year per $10,000 invested.
Which is cheaper, PRHSX or QAAGZX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and QAAGZX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.